Form D · Biotechnology
FLOWCO INC
Indianapolis, IN · CIK 0001437840
Offering snapshot reported Jun 16, 2010 · SEC filing
- Reported sold
- $1.85M Offering amount: $2M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jun 1, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 16, 2010 | Initial | $1,850,000 | No comparison | 7 | SEC filing |
| Nov 19, 2009 | Initial | $1,150,000 | No comparison | 3 | SEC filing |
| Jun 16, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06, 46
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-143601
Source: Form D, filed Jun 16, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Barnard | Director |
| Robert Cathcart | Director, Executive |
| Ronald Dollens | Director |
| David Johnson | Director |
| Ghassan S. Kassab | Director |
| William Mc Connell | Executive |
| Jennifer L. Rhodes | Executive |
| Frank Wantanabe | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9120 Otis Avenue Suite 201
Indianapolis, IN, 46216
Indianapolis, IN, 46216